📰 Human Use News
Page 128 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
July 19, 2022
Approval broadens indication for Daiichi Sankyo and AstraZeneca's ENHERTU across Europe to earlier use in HER2 positive metastatic breast cancer Based on groundbreaking DESTINY-Breast03 results
July 19, 2022
AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.
July 19, 2022
AstraZeneca's Enhertu approved in the EU for HER2-positive mBC
July 19, 2022
Investegate announcements from AstraZeneca PLC, Enhertu approved in EU for HER2-positive mBC
July 15, 2022
Horizon scanning at the MHRA leads to a proposed new framework to enable the supply and increase in the availability of innovative new medicinal products made at the point of care to patients.
July 14, 2022
The pilot will assess whether analysing raw clinical trial data is beneficial to regulatory decision making on marketing authorisation and post-authorisation applications.
July 12, 2022
The beaten-down vaccine stock's recent rebound could be just the beginning.
July 6, 2022
An adaptogen is a non-toxic substance that is believed to heighten the ability of the human body to resist the effects of stress and restore or support normal physiological functioning. This article discusses adaptogens in more detail.
July 5, 2022
Rinvoq could be approved to treat patients in the European Union with ulcerative colitis.
July 5, 2022
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recently adopted positive opinions for three biosimilar products.